These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31774391)

  • 41. Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses.
    Clarke JN; Davies LK; Calvert JK; Gliddon BL; Shujari WHA; Aloia AL; Helbig KJ; Beard MR; Pitson SM; Carr JM
    J Gen Virol; 2016 Jan; 97(1):95-109. PubMed ID: 26541871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Kitab B; Kohara M; Tsukiyama-Kohara K
    Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice.
    Prestwood TR; Morar MM; Zellweger RM; Miller R; May MM; Yauch LE; Lada SM; Shresta S
    J Virol; 2012 Dec; 86(23):12561-70. PubMed ID: 22973027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demethylation profile of the TNF-α promoter gene is associated with high expression of this cytokine in Dengue virus patients.
    Gomes AV; de Souza Morais SM; Menezes-Filho SL; de Almeida LG; Rocha RP; Ferreira JM; Dos Santos LL; Malaquias LC; Coelho LF
    J Med Virol; 2016 Aug; 88(8):1297-302. PubMed ID: 26792115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and T
    Sprokholt JK; Kaptein TM; van Hamme JL; Overmars RJ; Gringhuis SI; Geijtenbeek TBH
    J Immunol; 2017 Jun; 198(12):4764-4771. PubMed ID: 28507028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal Immunity and Vaccination Influence Disease Severity in Progeny in a Novel Mast Cell-Deficient Mouse Model of Severe Dengue.
    Mantri CK; Soundarajan G; Saron WAA; Rathore APS; Alonso S; St John AL
    Viruses; 2021 May; 13(5):. PubMed ID: 34066286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.
    Jaiswal S; Pearson T; Friberg H; Shultz LD; Greiner DL; Rothman AL; Mathew A
    PLoS One; 2009 Oct; 4(10):e7251. PubMed ID: 19802382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evasion of early innate immune response by 2'-O-methylation of dengue genomic RNA.
    Chang DC; Hoang LT; Mohamed Naim AN; Dong H; Schreiber MJ; Hibberd ML; Tan MJA; Shi PY
    Virology; 2016 Dec; 499():259-266. PubMed ID: 27716465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.
    Chan YK; Huang IC; Farzan M
    PLoS One; 2012; 7(3):e34508. PubMed ID: 22479637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans.
    Moi ML; Takasaki T; Omatsu T; Nakamura S; Katakai Y; Ami Y; Suzaki Y; Saijo M; Akari H; Kurane I
    J Gen Virol; 2014 Mar; 95(Pt 3):591-600. PubMed ID: 24323638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
    Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection.
    Branche E; Tang WW; Viramontes KM; Young MP; Sheets N; Joo Y; Nguyen AT; Shresta S
    Antiviral Res; 2018 Oct; 158():1-7. PubMed ID: 30071205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
    PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles.
    Gandini M; Reis SR; Torrentes-Carvalho A; Azeredo EL; Freire Mda S; Galler R; Kubelka CF
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):594-605. PubMed ID: 21894381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors.
    Phanthanawiboon S; Limkittikul K; Sakai Y; Takakura N; Saijo M; Kurosu T
    PLoS One; 2016; 11(2):e0148564. PubMed ID: 26844767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
    Tang WW; Grewal R; Shresta S
    Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.
    Surasombatpattana P; Hamel R; Patramool S; Luplertlop N; Thomas F; Desprès P; Briant L; Yssel H; Missé D
    Infect Genet Evol; 2011 Oct; 11(7):1664-73. PubMed ID: 21722754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infant mouse brain passaged Dengue serotype 2 virus induces non-neurological disease with inflammatory spleen collapse in AG129 mice after splenic adaptation.
    Rajmane Y; Shaikh S; Basha K; Reddy GE; Nair S; Kamath S; Sreejesh G; Rao H; Ramana V; Kumar AS
    Virus Res; 2013 May; 173(2):386-97. PubMed ID: 23337909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.